PT - JOURNAL ARTICLE AU - Bron, Gebbiena M. AU - Strimbu, Kathryn AU - Cecilia, Hélène AU - Lerch, Anita AU - Moore, Sean AU - Tran, Quan AU - Perkins, T. Alex AU - ten Bosch, Quirine A. TI - Over 100 years of Rift Valley Fever: a patchwork of data on pathogen spread and spillover AID - 10.1101/2021.02.18.21251916 DP - 2021 Jan 01 TA - medRxiv PG - 2021.02.18.21251916 4099 - http://medrxiv.org/content/early/2021/05/17/2021.02.18.21251916.short 4100 - http://medrxiv.org/content/early/2021/05/17/2021.02.18.21251916.full AB - During the past 100 years, Rift Valley fever virus (RVFV), a mosquito-borne virus, has caused potentially lethal disease in livestock, and has been associated with significant economic losses and trade bans. Spillover to humans occurs and can be fatal. Here, we combined data on RVF disease in humans (22 countries) and animals (37 countries) from 1931 to 2020 with seroprevalence studies from 1950 to 2020 (N=226) from publicly available databases and publications to draw a more complete picture of past and current RVFV epidemiology. RVFV has spread from its original focus in Kenya throughout Africa and into the Arabian Peninsula. Throughout the study period, seroprevalence increased in both humans and animals, suggesting potentially increased RVFV exposure. In 24 countries animals or humans tested positive for RVFV antibodies even though outbreaks had never been reported there, suggesting RVFV transmission may well go unnoticed. Among ruminants, sheep were most likely to be exposed during RVF outbreaks, but not during periods of cryptic spread. We discuss critical data gaps and highlight the need for detailed study descriptions, and long-term studies using a one health approach to further convert the patchwork of data to the tale of RFV epidemiology.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by an award from the Coalition for Epidemic Preparedness Innovations to the University of Notre Dame. In addition, TAP received support from USDA-NIFA AFRI Grant 2019-67015-28982 as part of the joint USDA-NSF-NIH-BBSRC-BSF Ecology and Evolution of Infectious Diseases program. HC was supported by FORESEE project funded by INRAE metaprogram GISA (Integrated Management of Animal Health), Region Pays de la Loire, CIRAD. GMB is supported by the Wageningen University Graduate School, postdoc-talent grant.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Data from previously published work was used.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData will be made available in Open Science Framework upon publication.